After presensitization with IV hematoporphyrin derivative (HpD). neoplasms in the tracheobronchial tree of 18 patients were treated by photodynamic therapy (PDT) with 630-nm light from a tunable dye argon laser system delivered through quartz fibers passed through the biopsy channel of a flexible br
โฆ LIBER โฆ
Photodynamic therapy with hematopophyrin derivative for endobronchial tumors
- Book ID
- 122924659
- Publisher
- Elsevier Science
- Year
- 1986
- Tongue
- English
- Weight
- 94 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Photodynamic therapy of endobronchial tu
โ
James S. Mccaughan Jr.; Thomas E. Williams Jr.; Bradley H. Bethel
๐
Article
๐
1986
๐
John Wiley and Sons
๐
English
โ 844 KB
O29 Photodynamic therapy for treatment o
โ
Y.A. Ragulin; M.A. Kaplan; V.N. Medvedev; V.N. Kapinus; V.V. Peters
๐
Article
๐
2010
๐
Elsevier Science
๐
English
โ 41 KB
Efficiency of chlorine photosensitizers
โ
Y. Ragulin; M. Kaplan; V. Medvedev; V. Kapinus; V. Peters
๐
Article
๐
2011
๐
Elsevier Science
๐
English
โ 54 KB
P-153 Endobronchial ablation of typical
โ
Downie, G.; Qureshi, A.; Childs, C.; Ron, A.; Claudo, S.; Rosa, C.; Gregory, L.
๐
Article
๐
2005
๐
Elsevier Science
๐
English
โ 127 KB
Endobronchial photodynamic therapy for l
โ
Gregory M. Loewen; Ravindra Pandey; David Bellnier; Barbara Henderson; Thomas Do
๐
Article
๐
2006
๐
John Wiley and Sons
๐
English
โ 129 KB
## Abstract ## Background and Objective Endobronchial photodynamic therapy (PDT) is a minimally invasive technique for the palliation of major airway obstruction from lung cancer, and for the treatment of endobronchial microinvasive lung cancer. ## Study Design Results of reported clinical trial
Survival after photodynamic therapy to n
โ
McCaughan, James S.
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 347 KB
๐ 2 views
Background: For the past 15 years we have used photodynamic therapy (PDT) to treat endobronchial tumors. Unfortunately patients who have non-primary lung cancer metastatic to bronchi and who have failed other treatment regimens may not be offered endobronchial tumor management. Thirteen patients wit